Aspen Pharmacare Holdings Limited (JSE:APN)

Aspen Pharmacare Holdings Balance Sheet

Financials in millions ZAR. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	15,998	6,409	12,337	10,912	6,183
Cash & Short-Term Investments	15,998	6,409	12,337	10,912	6,183
Cash Growth	149.62%	-48.05%	13.06%	76.48%	-27.73%
Accounts Receivable	10,788	10,646	10,299	10,087	8,243
Other Receivables	504	3,352	3,200	3,537	4,036
Receivables	11,292	13,998	13,499	13,624	12,279
Inventory	13,990	18,009	18,002	19,606	15,763
Prepaid Expenses	-	271	242	344	336
Other Current Assets	-	15	6	14	-
Total Current Assets	41,280	38,702	44,086	44,500	34,561
Property, Plant & Equipment	20,588	21,707	20,509	18,897	16,224
Goodwill	1,230	5,202	5,696	5,596	5,007
Other Intangible Assets	42,163	65,389	65,255	62,282	52,664
Long-Term Deferred Tax Assets	2,438	2,222	1,794	1,579	1,252
Long-Term Deferred Charges	-	1,823	771	822	987
Other Long-Term Assets	574	848	952	608	680
Total Assets	108,273	135,893	139,063	134,284	111,375

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	9,370	4,084	4,372	3,969	3,641
Accrued Expenses	-	5,975	5,314	5,404	5,468
Short-Term Debt	-	-	5,117	3,419	1,212
Current Portion of Long-Term Debt	6,072	4,356	5,923	4,325	10,329
Current Portion of Leases	-	256	274	163	124
Current Income Taxes Payable	394	385	791	900	613
Current Unearned Revenue	-	-	8	13	43
Other Current Liabilities	389	2,440	2,503	4,955	1,965
Total Current Liabilities	16,225	17,496	24,302	23,148	23,395
Long-Term Debt	9,497	31,263	24,819	21,103	10,361
Long-Term Leases	-	245	322	272	221
Long-Term Unearned Revenue	-	-	-	-	10
Pension & Post-Retirement Benefits	643	738	701	690	582
Long-Term Deferred Tax Liabilities	416	446	1,582	1,995	1,966
Other Long-Term Liabilities	1,122	812	2,476	840	3,898
Total Liabilities	27,903	51,000	54,202	48,048	40,433

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	1,725	2,017	2,017	2,017	2,017
Retained Earnings	-	58,092	60,763	58,134	54,341
Treasury Stock	-	-363	-364	-348	-233
Comprehensive Income & Other	78,645	25,147	22,445	26,433	14,817
Total Common Equity	80,370	84,893	84,861	86,236	70,942
Shareholders' Equity	80,370	84,893	84,861	86,236	70,942
Total Liabilities & Equity	108,273	135,893	139,063	134,284	111,375

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	15,569	36,120	36,455	29,282	22,247
Net Cash (Debt)	429	-29,711	-24,118	-18,370	-16,064
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.97	-66.92	-54.30	-41.36	-35.46
Filing Date Shares Outstanding	443.6	444.02	444.21	444.95	444.95
Total Common Shares Outstanding	443.6	444.02	444.21	444.95	444.95
Working Capital	25,055	21,206	19,784	21,352	11,166
Book Value Per Share	181.18	191.19	191.04	193.81	159.44
Tangible Book Value	36,977	14,302	13,910	18,358	13,271
Tangible Book Value Per Share	83.36	32.21	31.31	41.26	29.83
Land	-	868	800	834	628
Buildings	-	7,199	7,033	6,744	7,056
Machinery	-	13,646	11,889	11,067	10,756
Construction In Progress	-	8,492	7,698	6,530	4,647

Data Source: S&P Global Market Intelligence Last updated: Sep 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 23, 2026

Data Sources Report a data error